Literature DB >> 7296792

Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.

R Tatami, H Mabuchi, K Ueda, R Ueda, T Haba, T Kametani, S Ito, J Koizumi, M Ohta, S Miyamoto, A Nakayama, H Kanaya, H Oiwake, A Genda, R Takeda.   

Abstract

The relationship between the concentrations of intermediate-density lipoprotein (IDL) and other lipoproteins and the extent of coronary artery disease (CAD) was studied in 182 consecutive patients evaluated by selective coronary cineangiography. On univariate analysis, the extent of CAD correlated significantly and positively with very low density lipoprotein (VLDL) cholesterol, IDL cholesterol and low-density lipoprotein (LDL) cholesterol, and negatively with high-density lipoprotein (HDL) cholesterol. Analysis of four subgroups divided by IDL cholesterol and LDL cholesterol levels indicated that moderately increased levels of IDL cholesterol were closely associated with a high frequency of CAD. Moreover, multi-variate regression analysis demonstrated that IDL cholesterol for men, LDL cholesterol for men and women and HDL cholesterol for men were significant variables of use in the final weighting procedure. IDL cholesterol was closely associated with cholesterol-rich VLDL. This study shows that IDL and cholesterol-rich VLDL combine to contribute to the development of CAD.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296792     DOI: 10.1161/01.cir.64.6.1174

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

Review 1.  IDL, VLDL, chylomicrons and atherosclerosis.

Authors:  B G Nordestgaard; A Tybjaerg-Hansen
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins.

Authors:  S D Krasinski; J S Cohn; E J Schaefer; R M Russell
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 3.  The lipoproteins: predictors, protectors, and pathogens.

Authors:  B Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

4.  Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?

Authors:  B H Chung; J P Segrest; K Smith; F M Griffin; C G Brouillette
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

5.  [Persisting hyperlipidemias as risk factors of diabetic macroangiopathy].

Authors:  K H Vogelberg; G Meurers
Journal:  Klin Wochenschr       Date:  1986-06-02

6.  Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation.

Authors:  A Rivellese; G Riccardi; G Romano; R Giacco; L Patti; G Marotta; G Annuzzi; M Mancini
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

7.  Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.

Authors:  M I Uusitupa; L K Niskanen; O Siitonen; E Voutilainen; K Pyörälä
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

8.  Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?

Authors:  L Patti; L Di Marino; A Maffettone; G Romano; G Annuzzi; G Riccardi; A A Rivellese
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

9.  High remnant lipoprotein levels in patients with variant angina.

Authors:  Kunihisa Miwa; Toshinori Makita; Katsuhisa Ishii; Nobuaki Okuda; Ataru Taniguchi
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

10.  Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice.

Authors:  Ji Zhou; Geoff H Werstuck; Sárka Lhoták; Yuan Y Shi; Vivienne Tedesco; Bernardo Trigatti; Jeffrey Dickhout; Alana K Majors; Patricia M DiBello; Donald W Jacobsen; Richard C Austin
Journal:  FASEB J       Date:  2008-03-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.